Relationship of mannitol challenge to methacholine challenge and inflammatory markers in persistent asthmatics receiving inhaled corticosteroids

Lung

Volumn 190, Issue 5, 2012, Pages 513-521

  Anderson, William J ^a   Lipworth, Brian J ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Asthma; Inflammation; Inhaled corticosteroids; Mannitol; Methacholine; Nitric oxide

Indexed keywords

BIOLOGICAL MARKER; CORTICOSTEROID; EOSINOPHIL CATIONIC PROTEIN; FRACTIONAL EXHALED NITRIC OXIDE; MANNITOL; METHACHOLINE; NITRIC OXIDE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ASTHMA; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG EFFICACY; EXHALATION; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PRICK TEST; PRIORITY JOURNAL; PROVOCATION TEST; RESPIRATORY TRACT ALLERGY; RESPIRATORY TRACT INFLAMMATION; SALIVA; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SKIN PRICK TEST; SKIN TEST; SPIROMETRY;

ADRENAL CORTEX HORMONES; ANTI-ASTHMATIC AGENTS; ASTHMA; BREATH TESTS; BRONCHIAL HYPERREACTIVITY; BRONCHIAL PROVOCATION TESTS; EOSINOPHIL CATIONIC PROTEIN; FEMALE; HUMANS; MALE; MANNITOL; METHACHOLINE CHLORIDE; MIDDLE AGED; NITRIC OXIDE; SALIVA; SEVERITY OF ILLNESS INDEX;

EID: 84866736944     PISSN: 03412040     EISSN: 14321750     Source Type: Journal    
DOI: 10.1007/s00408-012-9396-6     Document Type: Article

References (24)

1. Anderson SD, Brannan J, Spring J, Spalding N, Rodwell LT, Chan K, Gonda I, Walsh A, Clark AR (1997) A new method for bronchial-provocation testing in asthmatic subjects using a dry powder of mannitol. Am J Respir Crit Care Med 156:758-765
2. Sverrild A, Porsbjerg C, Thomsen SF, Backer V (2010) Airway hyperresponsiveness to mannitol and methacholine and exhaled nitric oxide: a random-sample population study. J Allergy Clin Immunol 126:952-958
3. Sverrild A, Porsbjerg C, Thomsen SF, Backer V (2009) Diagnostic properties of inhaled mannitol in the diagnosis of asthma: a population study. J Allergy Clin Immunol 124(928-32):e1
4. Anderson SD, Smith CM (1991) Osmotic challenges in the assessment of bronchial hyperresponsiveness. Am Rev Respir Dis 143:S43-S46
5. Crapo RO, Casaburi R, Coates AL, Enright PL, Hankinson JL, Irvin CG, MacIntyre NR, McKay RT, Wanger JS, Anderson SD, Cockcroft DW, Fish JE, Sterk PJ (2000) Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med 161:309-329
6. Holzer K, Anderson SD, Chan HK, Douglass J (2003) Mannitol as a challenge test to identify exercise-induced bronchoconstriction in elite athletes. Am J Respir Crit Care Med 167:534-537
7. Cockcroft DW, Davis BE (2009) Diagnostic and therapeutic value of airway challenges in asthma. Curr Allergy Asthma Rep 9:247-253
8. Lipworth BJ, Short PM, Williamson PA, Clearie KL, Fardon TC, Jackson CM (2012) A randomized primary care trial of steroid titration against mannitol in persistent asthma: STAMINA trial. Chest 141:607-615
9. Green RH, Brightling CE, McKenna S, Hargadon B, Parker D, Bradding P, Wardlaw AJ, Pavord ID (2002) Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet 360:1715-1721
10. Currie GP, Haggart K, Lee DK, Fowler SJ, Wilson AM, Brannan JD, Anderson SD, Lipworth BJ (2003) Effects of mediator antagonism on mannitol and adenosine monophosphate challenges. Clin Exp Allergy 33:783-788
11. Currie GP, Haggart K, Brannan JD, Lee DK, Anderson SD, Lipworth BJ (2003) Relationship between airway hyperresponsiveness to mannitol and adenosine monophosphate. Allergy 58: 762-766
12. Brannan JD, Koskela H, Anderson SD, Chew N (1998) Responsiveness to mannitol in asthmatic subjects with exerciseand hyperventilation-induced asthma. Am J Respir Crit Care Med 158:1120-1126
13. Leuppi JD, Salome CM, Jenkins CR, Koskela H, Brannan JD, Anderson SD, Andersson M, Chan HK, Woolcock AJ (2001) Markers of airway inflammation and airway hyperresponsiveness in patients with well-controlled asthma. Eur Respir J 18:444-450
14. Miedinger D, Mosimann N, Meier R, Karli C, Florek P, Frey F, Scherer K, Surber C, Villiger B, Michel F, Leuppi JD (2010) Asthma tests in the assessment of military conscripts. Clin Exp Allergy 40:224-231
15. Dupont LJ, Rochette F, Demedts MG, Verleden GM (1998) Exhaled nitric oxide correlates with airway hyperresponsiveness in steroid-naive patients with mild asthma. Am J Respir Crit Care Med 157:894-898
16. Porsbjerg C, Brannan JD, Anderson SD, Backer V (2008) Relationship between airway responsiveness to mannitol and to methacholine and markers of airway inflammation, peak flow variability and quality of life in asthma patients. Clin Exp Allergy 38:43-50
17. Dweik RA, Boggs PB, Erzurum SC, Irvin CG, Leigh MW, Lundberg JO, Olin AC, Plummer AL, Taylor DR (2011) An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med 184:602-615
18. Short PM, Lipworth SI, Lipworth BJ (2011) Relationships between airway hyperresponsiveness, inflammation, and calibre in asthma. Lung 189:493-497
19. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J (2005) Standardisation of spirometry. Eur Respir J 26:319-338
20. American Thoracic Society: European Respiratory Society (2005) ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med 171:912-930
21. Koh GC, Shek LP, Kee J, Wee A, Ng V, Koh D (2010) Saliva and serum eosinophil cationic protein in asthmatic children and adolescents with and without allergic sensitization. J Asthma 47:61-65
22. Schmekel B, Ahlner J, Malmstrom M, Venge P (2001) Eosinophil cationic protein (ECP) in saliva: a new marker of disease activity in bronchial asthma. Respir Med 95:670-675
23. Bowton DL, Seeds MC, Bass DA (2003) Eosinophil cationic protein concentration in saliva does not correlate with eosinophil cationic protein concentration in sputum. Chest 123:372S
24. Fardon TC, Burns P, Barnes ML, Lipworth BJ (2006) A comparison of 2 extrafine hydrofluoroalkane-134a-beclomethasone formulations on methacholine hyperresponsiveness. Ann Allergy Asthma Immunol 96:422-430